Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Timigutuzumab |
Trade Name | |
Synonyms | TrasGEX |
Drug Descriptions |
Timigutuzumab is a second-generation ERBB2 (HER2) antibody derived from trastuzumab, which has potential antitumor activity and enhances antibody-dependent cellular cytotoxicity (PMID: 30018811). |
DrugClasses | HER2 (ERBB2) Antibody 72 |
CAS Registry Number | 1665274-14-5 |
NCIT ID | C152635 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Timigutuzumab | Timigutuzumab | 0 | 0 |